Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,700.00
Bid: 1,699.50
Ask: 1,700.50
Change: -5.00 (-0.29%)
Spread: 1.00 (0.059%)
Open: 1,705.00
High: 1,711.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Traders bide their time ahead of US jobs data

Mon, 28th Jul 2014 17:26

- BskyB paces gains- Lloyds fined $370m by UK and US authorities- Aberdeen Asset Management sees slight drop in AuMtechMARK 2,776.05 -0.83%FTSE 100 6,788.07 -0.05%FTSE 250 15,616.53 -0.48%The Footsie finished the session slightly lower as traders bided their time ahead of a raft of key data and events later in the week, including the latest US jobs report and a Federal Reserve policy meeting, on Wednesday. Acting as a backdrop, traders continued to closely monitor the worsening security situation in the Gaza strip and Ukraine.That came as US President Barack Obama was scheduled to speak on Monday with several European leaders concerning the crisis in the latter country, with markets eyeing the possibility of further European sanctions against the Russian Federation. The top flight index ended the day 3.48 points below Friday's close of 6,791.55. Financials led on the downside, with Aberdeen Asset Management heading up the fallers. In parallel, RBS gave back some of last Friday's sharp gains after it released its better than expected results ahead of schedule. Of note, Lloyds' share price was hit by news that it had agreed to pay $370m in fines to US and UK authorities.Pending home sales Stateside dropped 1.1% from a month earlier after rising 6% in May, according to the National Association of Realtors. Analysts had forecast a rise of 0.5%.BskyB tops leaderboard Back in the UK, British Sky Broadcasting topped the leaderboard. On Friday the company announced a deal to acquire 21st Century Fox's holdings in Sky Italia and Sky Deutschland. Reckitt Benkiser said that it expects market conditions to remain challenging in the second half of the year, particularly in the US and certain emerging markets, but that it was still on track to achieve its full year total revenue growth target of 4-5%. The household goods group also announced that it is planning to hive off its drug arm into a separate UK-listed company. Aberdeen Asset Management reported a pick-up in business in Asia and emerging markets, but revealed a slight fall in assets under management. Assets under management at June 30th totalled £322.5bn, down 0.6% on the £324.5m at the end of March 2014. Analysts at Credit Suisse upped their price target on shares of RBS to 310p from 280p previously, but retained their 'underperform' rating. The lender is progressing better than expected on the run-down of the assets of its non-core RBS Capital Resolution (RCR) arm, but its valuation already captures the "steady state" profile of returns which can be expected, according to the broker. A breakup of GlaxoSmithKline is a possibility as a result of a sweeping overhaul of the group, according to the Chief Executive of the pharmaceuticals giant, the Financial Times said. Budget airline Ryanair more than doubled its first quarter profit and said it was raising annual profit expectations, but warned of second-half pressure on fares from rival price-cutting. Ryanair said first quarter net profit rose 152% to €197m versus the same time a year ago due partly to a strong Easter, but cautioned that it compared with no holiday in the same period last time.Randgold Resources said it was focusing on its Tongon gold mine in Côte d'Ivoire where it is "continuing to make headway" in its efforts to overcome the technical issues that have affected its performance. Chief Executive Mark Bristow admitted this year's planned ramp-up in production had not been achieved due to the need to expand the flotation circuit and the mechanical failure of the recently installed Vibrocone crushers, intended to improve the recovery and throughput rate. National Grid reported a continued "solid operational and financial performance" between April 1st and July 27th, with the UK delivering operational efficiencies and progress with its investment programme, while the US saw a good operational performance.FTSE 100 - RisersBritish Sky Broadcasting Group (BSY) 904.50p +3.43%Reckitt Benckiser Group (RB.) 5,205.00p +2.66%Fresnillo (FRES) 940.00p +2.12%Pearson (PSON) 1,153.00p +1.86%HSBC Holdings (HSBA) 630.90p +1.48%Aggreko (AGK) 1,757.00p +1.15%BG Group (BG.) 1,212.00p +1.08%Randgold Resources Ltd. (RRS) 5,170.00p +1.08%Centrica (CNA) 315.20p +0.93%National Grid (NG.) 879.00p +0.92%FTSE 100 - FallersAberdeen Asset Management (ADN) 435.00p -5.31%Royal Bank of Scotland Group (RBS) 352.00p -3.35%Kingfisher (KGF) 295.80p -2.89%Royal Mail (RMG) 430.00p -2.52%Smith & Nephew (SN.) 1,033.00p -2.27%Hargreaves Lansdown (HL.) 1,047.00p -1.97%ARM Holdings (ARM) 846.00p -1.86%Meggitt (MGGT) 517.50p -1.62%Glencore (GLEN) 371.95p -1.47%IMI (IMI) 1,412.00p -1.40%FTSE 250 - RisersOphir Energy (OPHR) 207.10p +4.23%Debenhams (DEB) 66.20p +3.28%Infinis Energy (INFI) 239.10p +2.97%Drax Group (DRX) 686.50p +2.69%Petra Diamonds Ltd.(DI) (PDL) 216.60p +2.65%Exova Group (EXO) 240.00p +2.13%Restaurant Group (RTN) 610.00p +2.09%Rightmove (RMV) 2,208.00p +1.75%BH Global Ltd. USD Shares (BHGU) 11.99 +1.61%Fidelity China Special Situations (FCSS) 110.90p +1.37%FTSE 250 - FallersPets at Home Group (PETS) 170.10p -7.05%AO World (AO.) 200.00p -5.70%Xaar (XAR) 543.00p -4.65%CSR (CSR) 555.00p -4.47%Pace (PIC) 355.00p -3.64%JD Sports Fashion (JD.) 386.00p -3.45%Fidessa Group (FDSA) 2,055.00p -3.38%Howden Joinery Group (HWDN) 336.40p -3.19%Evraz (EVR) 95.00p -3.16%Ted Baker (TED) 1,685.00p -3.16%FTSE TechMARK - RisersOxford Biomedica (OXB) 2.92p +2.63%Sarossa (SARS) 1.93p +1.32%Gresham Computing (GHT) 127.00p +0.79%BATM Advanced Communications Ltd. (BVC) 17.00p +0.74%CML Microsystems (CML) 365.00p +0.69%XP Power Ltd. (DI) (XPP) 1,500.00p +0.67%RM (RM.) 165.00p +0.61%Kofax Limited (DI) (KFX) 420.00p +0.36%Skyepharma (SKP) 246.00p +0.10%IShares Euro Gov Bond 7-10YR UCITS ETF (IEGM) € 193.06 +0.09%FTSE TechMARK - FallersElectronic Data Processing (EDP) 72.50p -2.68%Torotrak (TRK) 18.75p -1.96%Vectura Group (VEC) 140.00p -1.93%Dialight (DIA) 939.50p -1.88%Optos (OPTS) 186.00p -1.85%E2V Technologies (E2V) 154.00p -1.75%Promethean World (PRW) 31.00p -1.59%Puricore (PURI) 35.50p -1.39%Anite (AIE) 90.25p -1.37%KCOM Group (KCOM) 93.50p -1.32%AB
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.